GleamWall
中文EN

UTMD UTAH MEDICAL PRODUCTS INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 706698 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-9.6%
TTM net income YoY-8.4%
TTM EPS YoY-5.6%
Revenue 3-yr CAGR-12.1%
Net income 3-yr CAGR-14.3%

Margins

Gross margin57.7%
Operating margin29.9%
Net margin30.5%
FCF margin31.1%
EBITDA margin32.4%

Returns

ROE8.8%
ROA8.5%
ROIC (approx.)23.7%
Asset turnover0.28x

Leverage & solvency

Liabilities / assets4.1%
Debt / equity0.00x
Current ratio21.23x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.08x
Accruals ratio-0.7%
Payout ratio37.0%
Capex / revenue1.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY2025*2025-12-31FY2024*2024-12-31
Income statement
Revenue$38.52M$40.90M
Cost of revenue$16.52M$16.76M
Gross profit$22.00M$24.14M
R&D expense$668,000$813,000
SG&A expense$7.88M$7.83M
Operating income$11.40M$13.59M
Pretax income$14.11M$16.80M
Income tax$2.82M$2.93M
Net income$11.29M$13.87M
EBITDA$12.23M$14.32M
EPS (basic)3.483.96
EPS (diluted)3.483.96
Weighted avg. shares (diluted)3.24M3.50M
Balance sheet
Cash & equivalents$85.76M$82.98M
Receivables$3.52M$4.09M
Inventory$7.93M$8.81M
Current assets$97.74M$96.33M
PP&E, net$9.91M$9.76M
Goodwill$14.05M$13.58M
Intangibles$840,000$2.87M
Total assets$122.54M$122.54M
Current liabilities$2.60M$3.76M
Long-term debt$225,000$282,000
Total debt$225,000$282,000
Total liabilities$3.27M$5.11M
Shareholders' equity$119.27M$117.43M
Net debt-$85.53M-$82.69M
Shares outstanding3.19M3.33M
Cash flow statement
Operating cash flow$14.69M$14.83M
Capital expenditure$371,000$230,000
Free cash flow$14.32M$14.60M
Investing cash flow-$371,000-$208,000
Financing cash flow-$12.34M-$23.84M
Depreciation & amortization$826,000$730,000
Stock-based compensation$373,000$256,000
Dividends paid$3.98M$4.26M
Share buybacks$8.36M$19.97M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.